Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2

Oncogene volume 21, pages 2939–2947 (2002)Cite this article

Abstract

The ARF tumour suppressor protein (p14ARF in human and p19ARF in mouse) is a major mediator of the activation of p53 in response to oncogenic stress. Little is known about the signalling pathways connecting oncogenic stimuli to the activation of ARF. Regulation of ARF occurs primarily at the transcriptional level and several modulators of ARF transcription have been identified. Notably, ectopic expression of E2F1 upregulates ARF transcriptionally, and both E2F1 and ARF have been implicated in apoptosis and cell-cycle arrest. We have used primary mouse fibroblasts deficient for E2F1, E2F2, or both to determine the possible role of these E2F proteins as upstream regulators of ARF in response to oncogenic stimuli and other stresses. In particular, we have studied the effects of oncogenic Ras and the viral oncoprotein E1A on ARF levels, neoplastic transformation, and sensitization to apoptosis. We have also examined the behaviour of the E2F-deficient MEFs with respect to immortalization and sensitivity to DNA damage. None of the ARF-mediated responses that we have analysed is significantly affected in E2F1−/−, E2F2−/− or E2F1/2−/− MEFs, and ARF is upregulated normally in all cases. Taken together, our results indicate that the activation of ARF in response to oncogenic stress can occur by E2F1- and E2F2-independent mechanisms. This challenges previous suggestions implicating E2F factors as key mediators in the activation of ARF by oncogenic stress.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ashcroft M, Vousden KH . 1999 Oncogene 18: 7637–7643

  • Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL, Vousden KH . 1998 Nature 395: 124–125

  • Blattner C, Sparks A, Lane D . 1999 Mol. Cell Biol. 19: 3704–3713

  • Brummelkamp TR, Kortlever RM, Lingbeek M, Trettel F, MacDonald ME, van Lohuizen M, Bernards R . 2001 J. Biol. Chem. 17: 17–

  • Dannenberg JH, van Rossum A, Schuijff L, te Riele H . 2000 Genes Dev. 14: 3051–3064

  • de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ, Lowe SW . 1998 Genes Dev. 12: 2434–2442

  • DeGregori J, Leone G, Miron A, Jakoi L, Nevins JR . 1997 Proc. Natl. Acad. Sci. USA 94: 7245–7250

  • Di Leonardo A, Linke SP, Clarkin K, Wahl GM . 1994 Genes Dev. 8: 2540–2551

  • Dimri GP, Itahana K, Acosta M, Campisi J . 2000 Mol. Cell Biol. 20: 273–285

  • Dyson N . 1998 Genes Dev. 12: 2245–2262

  • Eymin B, Karayan L, Seite P, Brambilla C, Brambilla E, Larsen CJ, Gazzeri S . 2001 Oncogene 20: 1033–1041

  • Field SJ, Tsai FY, Kuo F, Zubiaga AM, Kaelin Jr WG, Livingston DM, Orkin SH, Greenberg ME . 1996 Cell 85: 549–561

  • Garcia I, Murga M, Vicario A, Field SJ, Zubiaga AM . 2000 Cell Growth Differ. 11: 91–98

  • Harbour JW, Dean DC . 2000 Genes Dev. 14: 2393–2409

  • Harvey M, Sands AT, Weiss RS, Hegi ME, Wiseman RW, Pantazis P, Giovanella BC, Tainsky MA, Bradley A, Donehower LA . 1993 Oncogene 8: 2457–2467

  • Hofferer M, Wirbelauer C, Humar B, Krek W . 1999 Nucleic Acids Res. 27: 491–495

  • Hsieh JK, Yap D, O'Connor DJ, Fogal V, Fallis L, Chan F, Zhong S, Lu X . 2002 Mol. Cell Biol. 22: 78–93

  • Huang Y, Ishiko T, Nakada S, Utsugisawa T, Kato T, Yuan ZM . 1997 Cancer Res. 57: 3640–3643

  • Humbert PO, Verona R, Trimarchi JM, Rogers C, Dandapani S, Lees JA . 2000 Genes Dev. 14: 690–703

  • Inoue K, Roussel MF, Sherr CJ . 1999 Proc. Natl. Acad. Sci. 96: 3993–3998

  • Inoue K, Wen R, Rehg JE, Adachi M, Cleveland JL, Roussel MF, Sherr CJ . 2000 Genes Dev. 14: 1797–1809

  • Irwin M, Marin MC, Phillips AC, Seelan RS, Smith DI, Liu W, Flores ER, Tsai KY, Jacks T, Vousden KH, Kaelin Jr WG . 2000 Nature 407: 645–648

  • Ishida S, Huang E, Zuzan H, Spang R, Leone G, West M, Nevins JR . 2001 Mol. Cell Biol. 21: 4684–4699

  • Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA . 1994 Curr. Biol. 4: 1–7

  • Jacobs JJ, Keblusek P, Robanus-Maandag E, Kristel P, Lingbeek M, Nederlof PM, van Welsem T, van De Vijver MJ, Koh EY, Daley GQ, van Lohuizen M . 2000 Nat. Genet. 26: 291–299

  • Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M . 1999 Nature 397: 164–168

  • Jones SN, Sands AT, Hancock AR, Vogel H, Donehower LA, Linke SP, Wahl GM, Bradley A . 1996 Proc. Natl. Acad. Sci. USA 93: 14106–14111

  • Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ . 1999 Cancer Res. 59: 2217–2222

  • Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659

  • Khan SH, Moritsugu J, Wahl GM . 2000 Proc. Natl. Acad. Sci. USA 97: 3266–3271

  • Kowalik TF, DeGregori J, Leone G, Jakoi L, Nevins JR . 1998 Cell Growth Differ. 9: 113–118

  • Kowalik TF, DeGregori J, Schwarz JK, Nevins JR . 1995 J. Virol. 69: 2491–2500

  • Krimpenfort P, Quon KC, Mooi WJ, Loonstra A, Berns A . 2001 Nature 413: 83–86

  • Leone G, Sears R, Huang E, Rempel R, Nuckolls F, Park CH, Giangrande P, Wu L, Saavedra HI, Field SJ, Thompson MA, Yang H, Fujiwara Y, Greenberg ME, Orkin S, Smith C, Nevins JR . 2001 Mol. Cell 8: 105–113

  • Lin WC, Lin FT, Nevins JR . 2001 Genes Dev. 15: 1833–1844

  • Lissy NA, Davis PK, Irwin M, Kaelin WG, Dowdy SF . 2000 Nature 407: 642–645

  • Llanos S, Clark PA, Rowe J, Peters G . 2001 Nat. Cell Biol. 3: 445–452

  • Lowe SW, Ruley HE . 1993 Genes Dev. 7: 535–545

  • Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ . 1999 Genes Dev. 13: 2207–2217

  • Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM, Grossman SR . 2001 Proc. Natl. Acad. Sci. USA 98: 4455–4460

  • Meng RD, Phillips P, El-Deiry WS . 1999 Int. J. Oncol. 14: 5–14

  • Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F, Muller H, Helin K . 2001 Nat. Cell Biol. 3: 552–558

  • Muller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Propserini E, Vigo E, Oliner JD, Helin K . 2001 Genes Dev. 15: 267–285

  • Murga M, Fernández-Capetillo O, Field SJ, Moreno B, R-Borlado L, Fujiwara Y, Balomenos D, Vicario A, Carrera AC, Orkin SH, Greenberg ME, Zubiaga AM . 2001 Immunity 15: 959–970

  • Palmero I, McConnell B, Parry D, Brookes S, Hara E, Bates S, Jat P, Peters G . 1997 Oncogene 15: 495–503

  • Palmero I, Pantoja C, Serrano M . 1998 Nature 395: 125–126

  • Palmero I, Serrano M . 2001 Methods Enzymol. 333: 247–256

  • Pan H, Yin C, Dyson NJ, Harlow E, Yamasaki L, Van Dyke T . 1998 Mol. Cell 2: 283–292

  • Pantoja C, Serrano M . 1999 Oncogene 18: 4974–4982

  • Peeper DS, Dannenberg JH, Douma S, te Riela H, Bernards R . 2001 Nat. Cell Biol. 3: 198–203

  • Phillips AC, Bates S, Ryan KM, Helin K, Vousden KH . 1997 Genes Dev. 11: 1853–1863

  • Phillips AC, Ernst MK, Bates S, Rice NR, Vousden KH . 1999 Mol. Cell 4: 771–781

  • Prives C . 1998 Cell 95: 5–8

  • Radfar A, Unnikrishnan I, Lee HW, DePinho RA, Rosenberg N . 1998 Proc. Natl. Acad. Sci. USA 95: 13194–13199

  • Rempel RE, Saenz-Robles MT, Storms R, Morham S, Ishida S, Engel A, Jakoi L, Melhem MF, Pipas JM, Smith C, Nevins JR . 2000 Mol. Cell 6: 293–306

  • Robertson KD, Jones PA . 1998 Mol. Cell Biol. 18: 6457–6473

  • Ruas M, Peters G . 1998 Biochim. Biophys. Acta 1378: F115–F177

  • Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T . 2000 Genes Dev. 14: 3037–3050

  • Serrano M . 1997 Exp. Cell Res. 237: 7–13

  • Serrano M . 2000 Carcinogenesis 21: 865–869

  • Serrano M, Hannon GJ, Beach D . 1993 Nature 366: 704–707

  • Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA . 1996 Cell 85: 27–37

  • Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW . 1997 Cell 88: 593–602

  • Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA . 2001 Nature 413: 86–91

  • Sharpless NE, DePinho RA . 1999 Curr. Opin. Genet. Dev. 9: 22–30

  • Sherr CJ . 1996 Science 274: 1672–1677

  • Sherr CJ . 1998 Genes Dev. 12: 2984–2991

  • Sherr CJ . 2001a Nat. Rev. Mol. Cell Biol. 2: 731–737

  • Sherr CJ . 2001b Cell 106: 531–534

  • Sherr CJ, DePinho RA . 2000 Cell 102: 407–410

  • Sherr CJ, Weber JD . 2000 Curr. Opin. Genet. Dev. 10: 94–99

  • Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH, Peters G . 1998 EMBO J. 17: 5001–5014

  • Todaro GJ, Green H . 1963 J. Cell Biol. 17: 299–313

  • Tolbert D, Lu X, Yin C, Tantama M, Van Dyke T . 2002 Mol. Cell Biol. 22: 370–377

  • Trimarchi JM, Lees J . 2002 Nat. Rev. Mol. Cell Biol. 3: 11–20

  • Vigo E, Muller H, Prosperini E, Hateboer G, Cartwright P, Moroni MC, Helin K . 1999 Mol. Cell Biol. 19: 6379–6389

  • Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310

  • Weinberg RA . 1997 Cell 88: 573–575

  • Weitzman JB, Fiette L, Matsuo K, Yaniv M . 2000 Mol. Cell 6: 1109–1119

  • Woods DB, Vousden KH . 2001 Exp. Cell Res. 264: 56–66

  • Wu L, Levine AJ . 1997 Mol. Med. 3: 441–451

  • Wu L, Timmers C, Maiti B, Saavedra HI, Sang L, Chong GT, Nuckolls F, Giangrande P, Wright FA, Field SJ, Greenberg ME, Orkin S, Nevins JR, Robinson ML, Leone G . 2001 Nature 414: 457–462

  • Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ . 1996 Cell 85: 537–548

  • Zhu JW, DeRyckere D, Li FX, Wan YY, DeGregori J . 1999 Cell Growth Differ. 10: 829–838

  • Zhu JW, Field SJ, Gore L, Thompson M, Yang H, Fujiwara Y, Cardiff RD, Greenberg M, Orkin SH, DeGregori J . 2001 Mol. Cell Biol. 21: 8547–8564

  • Ziebold U, Reza T, Caron A, Lees JA . 2001 Genes Dev. 15: 386–391

  • Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF . 1998 Genes Dev. 12: 2424–2433

  • Zindy F, Quelle DE, Roussel MF, Sherr CJ . 1997 Oncogene 15: 203–211

Download references

Acknowledgements

We are grateful to Charles Sherr for providing ARF−/− animals, to Miguel Campanero for critical reading of the manuscript, and to Itxaso García for animal handling at the UPV. This work was supported in part by grants from the Spanish Ministry of Education and the Human Frontier Science Program (to M Serrano), and the Spanish Ministry of Health and the Basque Department of Education (to A Zubiaga). M Murga is the recipient of a predoctoral fellowship from the Basque Government. The Department of Immunology and Oncology (DIO) was founded and is supported by the Spanish Council for Scientific Research (CSIC) and The Pharmacia Corporation.

Author information

Authors and Affiliations

  1. Department of Immunology and Oncology, National Centre of Biotechnology, CSIC, Campus de Cantoblanco, Madrid, E-28049, Spain

    Ignacio Palmero & Manuel Serrano

  2. Department of Animal Biology and Genetics, Faculty of Sciences, University of the Basque Country, Campus de Leioa, Bilbao, E-48080, Spain

    Matilde Murga & Ana Zubiaga

  3. Institute of Molecular and Cellular Biology of Cancer, CSIC-University of Salamanca, Campus Miguel de Unamuno, Salamanca, E-37007, Spain

    Ignacio Palmero

Authors
  1. Ignacio Palmero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matilde Murga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ana Zubiaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Manuel Serrano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Manuel Serrano.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palmero, I., Murga, M., Zubiaga, A. et al. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2. Oncogene 21, 2939–2947 (2002). https://doi.org/10.1038/sj.onc.1205371

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205371

Keywords

This article is cited by

Search

Advanced search

Quick links